Literature DB >> 18220920

Advances in tissue and organ replacement.

Anthony Atala1.   

Abstract

Applications of regenerative medicine technology may offer new therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is a rapidly advancing aspect of regenerative medicine as well, and new discoveries here create new options for this type of therapy. For example, therapeutic cloning, in which the nucleus from a donor cell is transferred into an enucleated oocyte in order to extract pluripotent embryonic stem cells from the resultant embryo, provides another source of cells for cell-based tissue engineering applications. While stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting, indicating that regenerative medicine holds promise for the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18220920     DOI: 10.2174/157488808783489435

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  16 in total

1.  Looking into the crystal ball: kidney transplantation in 2025.

Authors:  Mohamed H Sayegh
Journal:  Nat Clin Pract Nephrol       Date:  2009-03

2.  Producing organs in the laboratory.

Authors:  Mark E Furth; Anthony Atala
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

3.  Stem cell platforms for regenerative medicine.

Authors:  Timothy J Nelson; Atta Behfar; Satsuki Yamada; Almudena Martinez-Fernandez; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

4.  The science and ethics of induced pluripotency: what will become of embryonic stem cells?

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

5.  The alignment and fusion assembly of adipose-derived stem cells on mechanically patterned matrices.

Authors:  Yu Suk Choi; Ludovic G Vincent; Andrew R Lee; Kyle C Kretchmer; Somyot Chirasatitsin; Marek K Dobke; Adam J Engler
Journal:  Biomaterials       Date:  2012-07-15       Impact factor: 12.479

6.  Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging.

Authors:  Fahd Azzabi; Markus Rottmar; Virginija Jovaisaite; Markus Rudin; Tullio Sulser; Andreas Boss; Daniel Eberli
Journal:  Tissue Eng Part C Methods       Date:  2014-08-04       Impact factor: 3.056

7.  Adipose-derived stem cells could sense the nano-scale cues as myogenic-differentiating factors.

Authors:  V Bayati; L Altomare; M C Tanzi; S Farè
Journal:  J Mater Sci Mater Med       Date:  2013-06-23       Impact factor: 3.896

Review 8.  Control of stem cell fate by physical interactions with the extracellular matrix.

Authors:  Farshid Guilak; Daniel M Cohen; Bradley T Estes; Jeffrey M Gimble; Wolfgang Liedtke; Christopher S Chen
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

9.  Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm.

Authors:  Timothy J Nelson; Atta Behfar; Andre Terzic
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

10.  Advanced technologies and the future of medicine and surgery.

Authors:  Richard M Satava
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.